These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 9343144

  • 1. Moclobemide and selegeline in the treatment of depression in Parkinson's disease.
    Steur EN, Ballering LA.
    J Neurol Neurosurg Psychiatry; 1997 Oct; 63(4):547. PubMed ID: 9343144
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Moclobemide and the reversible inhibitors of monoamine oxidase antidepressants.
    Priest RG.
    Acta Psychiatr Scand Suppl; 1990 Oct; 360():39-41. PubMed ID: 2248065
    [No Abstract] [Full Text] [Related]

  • 4. Combined and selective monoamine oxidase inhibition in the treatment of depression in Parkinson's disease.
    Jansen Steur EN, Ballering LA.
    Adv Neurol; 1999 Oct; 80():505-8. PubMed ID: 10410764
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Monoamine oxidase inhibitors in psychiatry. Status of current knowledge].
    Volz HP, Gleiter CH, Möller HJ.
    Nervenarzt; 1996 May; 67(5):339-47. PubMed ID: 9005342
    [Abstract] [Full Text] [Related]

  • 10. Depression in medical illness. Workshop report.
    Paykel E.
    Int Clin Psychopharmacol; 1993 Jan; 7(3-4):205-7. PubMed ID: 8468445
    [No Abstract] [Full Text] [Related]

  • 11. Moclobemide versus clomipramine in the treatment of depression: a single-centre study, Federal Republic of Germany.
    Funke HJ, Moritz E, Hellstern K, Malanowski H.
    Acta Psychiatr Scand Suppl; 1990 Jan; 360():46-7. PubMed ID: 2248069
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Moclobemide versus placebo in the treatment of depression: a multicentre study in Belgium.
    Botte L, Gilles C, Evrard JL, Mesters P, Wolfrum C, Berger M, Hellstern K, Ward J.
    Acta Psychiatr Scand Suppl; 1990 Jan; 360():42. PubMed ID: 2248066
    [Abstract] [Full Text] [Related]

  • 14. The advent of selective monoamine oxidase A inhibitor antidepressants devoid of the cheese reaction.
    Youdim MB.
    Acta Psychiatr Scand Suppl; 1995 Jan; 386():5-7. PubMed ID: 7717095
    [No Abstract] [Full Text] [Related]

  • 15. Recent clinical development with reversible and selective amine oxidase inhibitors: a valuable addition to the armamentarium. Chairman's introduction.
    Priest RG.
    J Clin Psychopharmacol; 1995 Aug; 15(4 Suppl 2):1S-3S. PubMed ID: 7593723
    [No Abstract] [Full Text] [Related]

  • 16. Moclobemide, imipramine and placebo in the treatment of major depression.
    Versiani M, Nardi AE, Mundim FD, Alves A, Schmid-Burgk W.
    Acta Psychiatr Scand Suppl; 1990 Aug; 360():57-8. PubMed ID: 2248073
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.